Publications
- B-Cell Receptor Signaling and Beyond: The Role of Igα (CD79a)/Igβ (CD79b) in Normal and Malignant B Cells2024 | First Faculty of Medicine
- Germline multigene panel testing of patients with endometrial cancer2023 | First Faculty of Medicine, Faculty of Science, Faculty of Medicine in Pilsen
- Circulating tumor DNA in Hodgkin lymphoma2022 | First Faculty of Medicine, Third Faculty of Medicine
- Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas2022 | First Faculty of Medicine
- Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer2019 | First Faculty of Medicine
- Germline CHEK2 Gene Mutations in Hereditary Breast Cancer Predisposition - Mutation Types and their Biological and Clinical Relevance2019 | First Faculty of Medicine
- Association of Germline CHEK2 Gene Variants with Risk and Prognosis of Non-Hodgkin Lymphoma2015 | First Faculty of Medicine
- Alterations of CHEK2 forkhead-associated domain increase the risk of Hodgkin lymphoma2011 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
- The AIB1 gene polyglutamine repeat length polymorphism and the risk of breast cancer development2011 | First Faculty of Medicine
- CHEK2 gene alterations in the forkhead-associated domain, 1100delC and del5395 do not modify the risk of sporadic pancreatic cancer.2010 | First Faculty of Medicine
Loading network view...